Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
IT
EN
☰
UNIFIND
|
UNIFIND
unipv.it
IT
EN
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
☰
Pubblicazioni
JOURNAL OF VIRAL HEPATITIS
Rivista
Codice:
E095011
ISSN:
1352-0504
Dati Generali
Dati Generali
Pubblicazioni (14)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis C
Articolo
Assessment of HCV RNA clearance under combination therapy for HCV genotype 1: performance of the transcription-mediated amplification (TMA) assay.
Articolo
Comparison of peginterferon pharmacokinetic and pharmacodynamic profiles
Articolo
HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: A randomized controlled trial
Articolo
Hepatitis C is more severe in drug users with human immunodeficiency virus infection
Articolo
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV‐infected patients treated in a real‐life setting
Articolo
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3.
Articolo
Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4.
Articolo
Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation
Articolo
The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: A meta-analysis
Articolo
The benefits of hepatitis C virus cure: Every rose has thorns
Articolo
The impact of HIV infection and men who have sex with men status on hepatitis A infection: The experience of two tertiary centres in Northern Italy during the 2017 outbreak and in the 2009-2016 period
Articolo
Who is more likely to respond to dual treatment with PEG-interferon and ribavirin for chronic hepatitis c? A gender-oriented analysis
Articolo
Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis.
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
